VEGFA and neoplasm: VEGF stimulates macrophage chemotaxis [7] into the tumor microenvironment, and we and others have shown that anti-VEGF therapy can reduce macrophage infiltration in pre-clinical tumor models (Table 1) [63,64,65,66,67].